ATYR
aTyr Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.50
−0.71%Leverage
- Debt / equity
- 0.23x
- Net debt / equity
- -0.10x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- 0.08x
Liquidity & coverage
- Current ratio
- 5.12x
- Quick ratio
- 5.12x
- Cash ratio
- 5.04x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $47.0M
Cash & dividend
- FCF / debt
- -4.85x
- Cash flow / debt
- -4.83x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026